MARKET RADAR
SENSEX     NIFTY      Refresh
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Strides Arcolab
Strides Arcolab
BSE: 532531|NSE: STAR|ISIN: INE939A01011|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 17, 17:00
880.30
-0.8 (-0.09%)
VOLUME 17,575
LIVE
NSE
May 17, 17:00
882.70
0.95 (0.11%)
VOLUME 118,185
News on Strides Arcolab
Select Year: 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2000-2004
FIIs look past political gloom to invest $10 bn in Jan-Mar 

8.58 pm | 09 May 2013 |  Source: CNBC-TV18

CNBC-TV18’s Nimesh Shah and Animesh Das report on the record inflow of USD 10 billion into the equity markets in the January-March quarter alone....

Strides Arcolab turns profitable with Q1 net at Rs 32 cr

11.48 am | 26 Apr 2013 |  Source: Moneycontrol.com

Pharmaceutical firm Strides Arcolab turned profitable with first quarter CY13 net profit at Rs 32 crore as against loss of Rs 28 crore in a year ago p...

Strides Arcolab Q1 results on April 25, 2013

11.38 am | 18 Apr 2013 |  Source: Moneycontrol.com

Strides Arcolab has informed BSE that a meeting of the Board of Directors of the Company will be held on April 25, 2013 inter alia, to consider the un...

Strides Arcolab gains on JV with Pfenex

1.29 pm | 17 Apr 2013 |  Source: Moneycontrol.com

The stock of Strides Arcolab moved up over one percent on Wednesday as the company's subsidiary Agila Biotech and US-based Pfenex Inc have entered int...

Strides Arcolab arm in JV with Pfenex for biosimilar drugs

1.28 pm | 17 Apr 2013 |  Source: CNBC-TV18

Strides Arcolab’s subsidiary Agila Biotech has signed a joint venture agreement with US-based Pfenex for developing, manufacturing and commercializi...

Pfenex Inc. and Agila Biotech signs JV to develop biosimilar products

7.31 pm | 16 Apr 2013 |  Source: Moneycontrol.com

Strides Arcolab has informed BSE regarding a Press Release dated April 16, 2013, titled ...

Accumulate Strides Arcolab; target Rs 917: Dolat Capital

5.11 pm | 04 Mar 2013 |  Source: Moneycontrol.com

Dolat Capital is bullish on Strides Arcolab and has recommended accumulate rating on the stock with a target price of Rs 917 in its March 04, 2013 res...

See pharma sector's Q3 topline to grow 22%: Motilal Oswal

11.54 am | 12 Jan 2013 |  Source: Moneycontrol.com

Motilal Oswal has come out with its earnings estimates for pharmaceuticals sector for the quarter ended December 2012. The research firm expects the t...

1 2
Quick Links for Strides Arcolab
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.